Gonadotropin-releasing hormone receptor

Gonadotropin-releasing hormone receptor
Identifiers
Symbol	GNRHR
Alt. symbols	GnRH-R; LRHR;
Entrez	2798
HUGO	4421
OMIM	138850
RefSeq	NM_000406
UniProt	P30968
Other data
Locus	Chr. 4 q21.2

Gonadotropin-releasing hormone (type 2) receptor 2
Identifiers
Symbol	GNRHR2
Entrez	114814
HUGO	16341
RefSeq	NR_002328
UniProt	Q96P88
Other data
Locus	Chr. 1 q12

The gonadotropin-releasing hormone receptor (GnRHR), also known as the luteinizing hormone releasing hormone receptor (LHRHR), is a member of the seven-transmembrane, G-protein coupled receptor (GPCR) family. It is the receptor of gonadotropin-releasing hormone (GnRH). The GnRHR is expressed on the surface of pituitary gonadotrope cells as well as lymphocytes, breast, ovary, and prostate.

This receptor is a 60 kDa G protein-coupled receptor and resides primarily in the pituitary and is responsible for eliciting the actions of GnRH after its release from the hypothalamus. Upon activation, the LHRHr stimulates tyrosine phosphatase and elicits the release of LH from the pituitary.

Evidence exists showing the presence of GnRH and its receptor in extrapituitary tissues as well as a role in progression of some cancers.

Function

Following binding of GnRH, the GnRHR associates with G-proteins that activate a phosphatidylinositol (PtdIns)-calcium second messenger system. Activation of the GnRHR ultimately causes the release of follicle stimulating hormone (FSH) and luteinizing hormone (LH).

Genes

There are two major forms of the GNRHR, each encoded by a separate gene (GNRHR and GNRHR2).

Alternative splicing of the GNRHR gene, GNRHR, results in multiple transcript variants encoding different isoforms. More than 18 transcription initiation sites in the 5' region and multiple polyA signals in the 3' region have been identified for GNRHR.

Regulation

The GnRHR responds to GnRH as well as to synthetic GnRH agonists. Agonists stimulate the receptor, however prolonged exposure leads to a downregulation effect resulting in hypogonadism, an effect that is often medically utilized. GnRH antagonists block the receptor and inhibit gonadotropin release. GnRHRs are further regulated by the presence of sex hormones as well as activin and inhibin.

Ligands

Agonists

Peptides

• Azagly-nafarelin
• Buserelin
• Deslorelin
• Fertirelin
• GnRH
• Gonadorelin
• Goserelin
• Histrelin
• Lecirelin
• Leuprorelin
• Nafarelin
• Peforelin
• Triptorelin

Antagonists

Peptides

• Abarelix
• Cetrorelix
• Degarelix
• Ganirelix
• Ozarelix

Non-peptides

• Elagolix
• Linzagolix
• Opigolix
• Relugolix
• Sufugolix

Clinical implications

Defects in the GnRHR are a cause of hypogonadotropic hypogonadism (HH).

Normal puberty begins between ages 8 and 14 in girls and between 9 and 14 in boys. Puberty, however, for some children can come much sooner or much later or in many cases never occurs and thereby contributes to the estimated 35-70 million infertile couples worldwide. Among children, the abnormally early or late onset of puberty exerts intense emotional and social stress that too often goes untreated.

The timely onset of puberty is regulated by many factors and one factor that is often referred to as the master regulator of puberty and reproduction is GnRH. This peptide hormone is produced in the hypothalamus but gets secreted and acts upon GnRHRs in the anterior pituitary to exert its effects on reproductive maturation.

Understanding how GnRHR functions has been key to developing clinical strategies to treat reproductive-related disorders.

See also

• GnRH modulator

External links

• "Gonadotrophin-Releasing Hormone Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
• GNRHR+protein,+human at the US National Library of Medicine Medical Subject Headings (MeSH)